UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 408

Sortiert nach

Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs

Cancer research (Chicago, Ill.), 2008-10, Vol.68 (19), p.8031-8038

2008

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Preclinical Evaluation of QS-21 Variants Leading to Simplified Vaccine Adjuvants and Mechanistic Probes

Journal of the American Chemical Society, 2012-08, Vol.134 (32), p.13448-13457

2012

Link zum Volltext

Verfügbarkeit prüfen

Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer

Expert review of vaccines, 2011-04, Vol.10 (4), p.463-470

2011

Link zum Volltext

Verfügbarkeit prüfen

A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia

Nucleic acids research, 2011-03, Vol.39 (6), p.2458

2011

Link zum Volltext

Verfügbarkeit prüfen

Development of a minimal saponin vaccine adjuvant based on QS-21

Nature chemistry, 2014-07, Vol.6 (7), p.635

2014

Link zum Volltext

Verfügbarkeit prüfen

Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma

Blood, 2008-06, Vol.111 (11), p.5350-5358

2008

Link zum Volltext

Verfügbarkeit prüfen

The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies

Blood, 2008-10, Vol.112 (7), p.2906-2916

2008

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol

Bioorganic & medicinal chemistry, 2014-11, Vol.22 (21), p.5917-5923

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis

Blood, 2010-04, Vol.115 (14), p.2919-2927

2010

Link zum Volltext

Verfügbarkeit prüfen

Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics

The Journal of clinical investigation, 2004-10, Vol.114 (8), p.1107-1116

2004

Link zum Volltext

Verfügbarkeit prüfen

The Warburg Effect Confers Adverse Outcome in Chronic Lymphocytic Leukemia

Clinical lymphoma, myeloma and leukemia, 2014-09, Vol.14, p.S131-S131

2014

Link zum Volltext

Verfügbarkeit prüfen

Soluble GM-CSF Receptor α Is Cytotoxic to Myeloid Cells in a Manner That Is Independent of GM-CSF Binding Inhibition

Blood, 2009-11, Vol.114 (22), p.3618-3618

2009

Link zum Volltext

Verfügbarkeit prüfen

Reply

Cancer research (Chicago, Ill.), 2009-11, Vol.69 (22), p.8830-8831

2009

Link zum Volltext

Verfügbarkeit prüfen

Elevated Mitochondrial Membrane Potential in CLL Cells Is Associated with a more aggressive Natural History

Blood, 2011-11, Vol.118 (21), p.1765-1765

2011

Link zum Volltext

Verfügbarkeit prüfen

Aerobic Glycolysis Predicts Outcome in Early Chronic Lymphocytic Leukemia

Blood, 2012-11, Vol.120 (21), p.2482-2482

2012

Link zum Volltext

Verfügbarkeit prüfen

High Mitochondrial Membrane Potential Identifies Patients with Myeloproliferative Neoplasms with a More Aggressive Natural History

Blood, 2010-11, Vol.116 (21), p.1992-1992

2010

Link zum Volltext

Verfügbarkeit prüfen

Malignant Cells in the Marrow and Blood of Patients with Hematopoietic Malignancies Have Higher Mitochondrial Membrane Potential as Measured with the Potentiometric Dye JC-1

Blood, 2006-11, Vol.108 (11), p.2367-2367

2006

Link zum Volltext

Verfügbarkeit prüfen

Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma. Commentary

Blood, 2008, Vol.111 (11)

2008

Link zum Volltext

Verfügbarkeit prüfen

Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs

Blood, 2005-11, Vol.106 (11), p.498-498

2005

Link zum Volltext

Verfügbarkeit prüfen

Pseudopotential inversion scheme

Physical review. B, Condensed matter, 1986-05, Vol.33 (10), p.7139-7143

1986

Link zum Volltext

Verfügbarkeit prüfen

Macrophages and Tissue Injury: Agents of Defense or Destruction?

Annual review of pharmacology and toxicology, 2011-01, Vol.51 (1), p.267-288

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With Metastatic BRAF-Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF Inhibitor

Journal of clinical oncology, 2013-02, Vol.31 (4), p.482-489

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 408

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(378)
Mit Volltextzugriff
(352)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(296)
Life Sciences & Biomedicine
(268)
Humans
(169)
Male
(105)
Female
(101)
Biological And Medical Sciences
(95)
Animals
(70)
Adult
(64)
Medical Sciences
(63)
Middle Aged
(53)
Biochemistry & Molecular Biology
(42)
Mice
(37)
Fundamental And Applied Biological Sciences. Psychology
(35)
Aged
(34)
Physical Sciences
(30)
Microbiology
(27)
Adolescent
(26)
Surgery
(26)
Cardiovascular System & Cardiology
(23)
Mutation
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs

Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia

Synthesis and Preclinical Evaluation of QS-21 Variants Leading to Simplified Vaccine Adjuvants and Mechanistic Probes

Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer

A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia

Development of a minimal saponin vaccine adjuvant based on QS-21

Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma

The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies

Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol

Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis

Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics

The Warburg Effect Confers Adverse Outcome in Chronic Lymphocytic Leukemia

Soluble GM-CSF Receptor α Is Cytotoxic to Myeloid Cells in a Manner That Is Independent of GM-CSF Binding Inhibition

Reply

Genomic Analysis of Serial Samples from CLL Patients Identifies Clonal Events Associated with Disease Progression

Extensive High-Depth Sequencing Of Longitudinal CLL Samples Identifies Frequent Mutations In MAP Kinase Signaling and Novel Mutations Activating Notch and Beta-Catenin

Elevated Mitochondrial Membrane Potential in CLL Cells Is Associated with a more aggressive Natural History

Aerobic Glycolysis Predicts Outcome in Early Chronic Lymphocytic Leukemia

High Mitochondrial Membrane Potential Identifies Patients with Myeloproliferative Neoplasms with a More Aggressive Natural History

Malignant Cells in the Marrow and Blood of Patients with Hematopoietic Malignancies Have Higher Mitochondrial Membrane Potential as Measured with the Potentiometric Dye JC-1

Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma. Commentary

Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs

Pseudopotential inversion scheme

Macrophages and Tissue Injury: Agents of Defense or Destruction?

Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With Metastatic BRAF-Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF Inhibitor

Suchergebnisse filtern